Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

1.448 +0.148 (+11.38%)
Streaming Delayed Price Updated: 3:42 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 189,935
Open 1.300
Bid (Size) 1.420 (35)
Ask (Size) 1.450 (7)
Prev. Close 1.300
Today's Range 1.300 - 1.448
52wk Range 0.7749 - 3.470
Shares Outstanding 17,559,179
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Lexaria Attending the 27th Annual H.C. Wainwright Global Investment Conference
Via ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-37.0%
-37.0%
1 Month
+73.1%
+73.1%
3 Month
+43.4%
+43.4%
6 Month
-1.3%
-1.3%
1 Year
-57.0%
-57.0%

More News

Read More
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
Via ACCESS Newswire
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
Via ACCESS Newswire
Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
Via ACCESS Newswire
Lexaria Attending BIO International Convention
Via ACCESS Newswire
The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience
Via ACCESS Newswire
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry
Via ACCESS Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide
Via ACCESS Newswire
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
Via ACCESS Newswire
Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company
Via ACCESS Newswire
Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
These stocks that are showing activity before the opening bell on Friday.
Via Chartmill
Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Lexaria Announces $2 Million Registered Direct Offering of Common Stock
Via ACCESS Newswire
Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology
Via ACCESS Newswire
Lexaria Updates its Ongoing Human Study GLP-1-H24-4
Via ACCESS Newswire
Lexaria's Human GLP-1 Study #5 Begins Dosing
Via ACCESS Newswire
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
Via ACCESS Newswire

Frequently Asked Questions

Is Lexaria Bioscience Corp. - Common Stock publicly traded?
Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.
What exchange does Lexaria Bioscience Corp. - Common Stock trade on?
Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?
The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market
What is the current price of Lexaria Bioscience Corp. - Common Stock?
The current price of Lexaria Bioscience Corp. - Common Stock is 1.448
When was Lexaria Bioscience Corp. - Common Stock last traded?
The last trade of Lexaria Bioscience Corp. - Common Stock was at 09/16/25 03:42 PM ET
What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?
The market capitalization of Lexaria Bioscience Corp. - Common Stock is 25.42M
How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?
Lexaria Bioscience Corp. - Common Stock has 25M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.